Endocrinology, Vol 136, 3353-3359, Copyright © 1995 by Endocrine Society

ARTICLES

Suppression of development of experimental autoimmune thyroiditis by oral administration of thyroglobulin

VC Guimaraes, J Quintans, ME Fisfalen, FH Straus, K Wilhelm, A Medeiros-Neto and LJ DeGroot
Department of Medicine, University of Chicago, Illinois 60637, USA.

Experimental autoimmune thyroiditis (EAT), which to some extent represents an experimental model of human chronic lymphocytic thyroiditis, is an organ-specific autoimmune disease characterized by autoantibody production to thyroid antigens (Ag) and mononuclear infiltration of the thyroid gland. EAT induced by immunization with human thyroglobulin (hTG) with Freund's adjuvant in CBA/J (H-2K) mice is associated with prominent B and T cell responses. We report that oral administration of hTG effectively reduces the immune responses in EAT in mice in an Ag-specific manner. Both cellular and humoral immune responses are reduced in a dose-dependent manner. Histological evidence of disease is dramatically reduced. Suppression of the immune responses is seen 2 weeks after Ag challenge, with partial inhibition of proliferative and antibody responses. Six weeks after immunization, further inhibition is observed of both T and B cell responses. Hyporesponsiveness of T and B cell reactivity is seen only to hTG; T and B cell responses to other immunogens are not affected, including purified protein derivative and the nonrelated Ag BSA. This model may provide the basis for immunotherapy of autoimmune thyroid diseases in man.

This article has been cited by other articles:

				L. Bartalena, A. Pinchera, and C. Marcocci Management of Graves' Ophthalmopathy: Reality and Perspectives Endocr. Rev., April 1, 2000; 21(2): 168 - 199. [Abstract] [Full Text]

				P GARSIDE, A M. MOWAT, and A KHORUTS Oral tolerance in disease Gut, January 1, 1999; 44(1): 137 - 142. [Full Text] [PDF]